BE900089A - Utilisation de mini-somatostatines en therapeutique. - Google Patents

Utilisation de mini-somatostatines en therapeutique.

Info

Publication number
BE900089A
BE900089A BE1/11055A BE1011055A BE900089A BE 900089 A BE900089 A BE 900089A BE 1/11055 A BE1/11055 A BE 1/11055A BE 1011055 A BE1011055 A BE 1011055A BE 900089 A BE900089 A BE 900089A
Authority
BE
Belgium
Prior art keywords
mini
somatostatins
therapeutics
somatostatin
parenterally
Prior art date
Application number
BE1/11055A
Other languages
English (en)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of BE900089A publication Critical patent/BE900089A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/31—Somatostatins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'utilisation des mini-somatostatines pour le traitement de la démence sénille évolutive. Les mini-somatostatines de formule I - V sont administrées simultanément avec du glucose, par voie parentérale.
BE1/11055A 1983-07-08 1984-07-05 Utilisation de mini-somatostatines en therapeutique. BE900089A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838318552A GB8318552D0 (en) 1983-07-08 1983-07-08 Organic compounds

Publications (1)

Publication Number Publication Date
BE900089A true BE900089A (fr) 1985-01-07

Family

ID=10545445

Family Applications (1)

Application Number Title Priority Date Filing Date
BE1/11055A BE900089A (fr) 1983-07-08 1984-07-05 Utilisation de mini-somatostatines en therapeutique.

Country Status (7)

Country Link
JP (1) JPS6036421A (fr)
AU (1) AU574081B2 (fr)
BE (1) BE900089A (fr)
DE (1) DE3424279A1 (fr)
GB (1) GB8318552D0 (fr)
IT (1) IT1191252B (fr)
PH (1) PH24676A (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997011962A1 (fr) * 1995-09-29 1997-04-03 Biomeasure, Incorporated Analogues peptides cycliques de somatostatine

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3432324A1 (de) * 1984-09-03 1986-03-13 Henkel KGaA, 4000 Düsseldorf Verfahren zur regelung des disalzgehalts in (alpha)-sulfofettsaeureester-tensiden
US5089472A (en) * 1988-01-26 1992-02-18 Laboratorios Serono S.A. Use of growth hormone releasing factor for improving mental function
PT1787658E (pt) 2005-11-10 2012-06-22 Chemi Spa Formulações de libertação sustentada de análogos de somatostatina inibidores da hormona do crescimento

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4328214A (en) * 1979-07-04 1982-05-04 Ciba-Geigy Corporation Cyclopeptides and pharmaceutical preparations thereof and also processes for their manufacture

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997011962A1 (fr) * 1995-09-29 1997-04-03 Biomeasure, Incorporated Analogues peptides cycliques de somatostatine
US5708135A (en) * 1995-09-29 1998-01-13 Biomeasure Incorporated Cyclic peptide analogs of somatostatin
US6001801A (en) * 1995-09-29 1999-12-14 Biomeasure, Inc. Cyclic peptide analogs of somatostatin

Also Published As

Publication number Publication date
AU574081B2 (en) 1988-06-30
IT8448508A1 (it) 1986-01-05
DE3424279A1 (de) 1985-01-17
IT8448508A0 (it) 1984-07-05
GB8318552D0 (en) 1983-08-10
PH24676A (en) 1990-09-07
IT1191252B (it) 1988-02-24
AU3036384A (en) 1985-01-10
JPS6036421A (ja) 1985-02-25

Similar Documents

Publication Publication Date Title
DE3875786D1 (de) Schutzbekleidung des typs sicxnyozht erhalten durch behandlung mit plasma.
DE3679139D1 (de) Behandlung des aktivschlamms im abwasser.
OA08617A (fr) Inhibiteurs de métalloendopeptidase neutre dans le traitement de l'hypertention.
ATE38672T1 (de) 7-oxabicycloheptan aminosubstituierte prostaglandinaehnliche verbindungen.
NL300140I2 (nl) Galanthamine, of verbindingen die eraan analoog zijn, voor behandeling van de ziekte van Alzheimer.
NL7804815A (nl) Bereiding van geconcentreerde bacteriecultures voor "direct-vat-set" kaasbereiding.
DE3782214D1 (de) Mittel zur behandlung des scheidenmilieus.
FR2361404A1 (fr) Nouvelles 7-boxyiminoacylcephalosporines, leurs procedes de preparation et leur application en therapeutique
MY103210A (en) Arylpiperazinyl-alkylene-phenyl-heterocyclic compounds.
BE900089A (fr) Utilisation de mini-somatostatines en therapeutique.
OA05587A (fr) Pulvérisateur portatif, notamment pour le traitement des cultures.
BE855706A (fr) Meuble pour s'asseoir
FI922428A0 (fi) Nya 2-amino-5-cyan-1,4- dihydropyridiner, foerfarande foer deras framstaellning och deras anvaendning i laekemedel.
DE69112573D1 (de) Immunstimulierendes arzneimittel, das polare glycopeptidolipide von mycobakterium-chelonae enthält.
DE3886371D1 (de) Herstellung des hblv-virus in der hsb-2 zell-linie.
FR2584073B1 (fr) Analogues d'amino-prostaglandines a substituant 5,6-epoxy-7-oxabicycloheptane, utilisables pour le traitement des thromboses
DE68925037D1 (de) Für den benutzer einstellbarer sessel.
FR2713657B1 (fr) Nouveaux vecteurs pour le traitement du sida.
DE3578135D1 (de) Behandlung eines ultrafiltrats durch elektrodialyse.
CA1268468C (fr) Analogues des prostaglandines avec groupement thiabicycloheptane substitue
IT8421820A0 (it) Preparazione del 3,3,3-trifluoro-2-trifluorometilpro pene.
FR2359841A1 (fr) Guanidines, leur procede de preparation et leur application en therapeutique
FR2663539B1 (fr) Utilisation de la d-fenfluramine pour l'obtention de medicaments destines au traitement des deficiences immunitaires chez le sujet age.
FR2656528B1 (fr) Formule combinee de cimetidine-pirenzepine pour le traitement des ulceres simples de l'estomac et des erosions et procede de traitement.
OA08609A (fr) Composition pharmaceutique pour le traitement des infections bactériennes.

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: SANDOZ S.A.

Effective date: 19940731